Previous Close | 1.2800 |
Open | 1.2800 |
Bid | N/A x N/A |
Ask | N/A x N/A |
Day's Range | 1.2700 - 1.3700 |
52 Week Range | 0.4640 - 1.8200 |
Volume | |
Avg. Volume | 268,856 |
Market Cap | 268.058M |
Beta (5Y Monthly) | 2.52 |
PE Ratio (TTM) | N/A |
EPS (TTM) | N/A |
Earnings Date | N/A |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | N/A |
Ascend Wellness Holdings, Inc. ("AWH," "Ascend" or the "Company") (CSE: AAWH.U) (OTCQX: AAWH), a multi-state, vertically integrated cannabis operator, proudly announces support for the reports citing the Drug Enforcement Agency's ("DEA") decision to accept the recommendation of the U.S. Department of Health and Human Services ("HHS") to move cannabis from Schedule I to Schedule III of the Controlled Substances Act ("CSA").
Ascend Wellness Holdings, Inc. ("AWH" or the "Company") (CSE: AAWH-U.CN) (OTCQX: AAWH), a leading multi-state, vertically integrated cannabis operator, today announced that it will hold a conference call on Tuesday, May 7, 2024, at 8:30 AM ET following the release of its first quarter 2024 financial results.
Ascend Wellness Holdings, Inc. ("AWH" or the "Company") (CSE: AAWH-U.CN) (OTCQX: AAWH), a multi-state, vertically integrated cannabis operator, proudly announces that its CEO, John Hartmann, has recently acquired 192,500 shares of Class A common stock in the Company, demonstrating his strong belief in its mission and future prospects.